Theator, the Surgical Intelligence platform leveraging AI and computer vision to improve surgeon performance, today announced that it has raised $15.5M in an oversubscribed Series A round led by Insight Partners, joined by new investor Blumberg Capital, and supported by all existing investors including NFX, StageOne Ventures, KdT Ventures, and iAngels. Several notable individual investors, including 23andMe's Co-founder and CEO Anne Wojcicki, former Netflix Chief Product Officer Neil Hunt, and Zebra Medical Vision's Co-founder Eyal Gura, also participated in the round. The round will be used by Theator to scale its commercial operations and partnerships with U.S. providers, grow its R&D team and cement its status as a world-leading provider of AI-powered Surgical Intelligence solutions. Theator has raised a total of $18.5 million to date.

Theator is pioneering the Surgical Intelligence revolution, with an innovative platform built for surgeons by surgeons to address the variability and disparity in surgical care. Combining highly sophisticated artificial intelligence and computer vision technologies, Theator puts defining intraoperative moments in surgeons' hands so that they can continuously perfect their surgical craft. Theator is partnering with visionary surgeons, hospitals, professional societies, and research institutions to create a smarter, more transparent operating room while empowering surgeons to raise their expertise to the highest possible level. Based in Palo Alto, California, the company is paving the path for real-time surgical decision-support, creating a stronger, healthier world. For more information, visit https://theator.io/.